People: American Institute Of Physics Appoints Retiring IBM Executive As Director And CEO, Former DOE Genome Project Director To Oversee Biotech Launch

Author: Ron Kaufman, p.21 Marc H. Brodsky says that when he takes over as the director and chief executive officer of the American Institute of Physics (AIP) on November 1, one important goal of his will be to establish a positive public perception of physics. "We must begin to give the public some understanding of what physics is and what physicists do," says Brodsky, 54, a researcher in amorphous semiconductors who has been working at the IBM Thomas J. Watson Research Center since 196

Written byRon Kaufman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Author: Ron Kaufman, p.21

Marc H. Brodsky says that when he takes over as the director and chief executive officer of the American Institute of Physics (AIP) on November 1, one important goal of his will be to establish a positive public perception of physics.

"We must begin to give the public some understanding of what physics is and what physicists do," says Brodsky, 54, a researcher in amorphous semiconductors who has been working at the IBM Thomas J. Watson Research Center since 1968.

"My favorite wording of the problem is the joke: `The best way to stop a conversation dead at a cocktail party is to tell somebody you're a physicist,' " he says. "That conveys an image. If you say you're a chemist, [laypeople] picture test tubes and Bunsen burners. If you say you're a biologist, perhaps they think of someone looking in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies